Stay updated on Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial page.

Latest updates to the Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedFooter now displays Revision: v3.3.2, replacing the prior v3.2.0; this is a minor UI/version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedRemoved a general operating-status notice about government funding and NIH operations, which does not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check34 days agoChange DetectedThe study contact information was updated: Marilyn Donaldson was removed as contact and Robert Martin, MD, PhD is now listed with updated phone and email. Primary Completion is now estimated for 2028-06-01 and Study Completion for 2029-04-01, and a new 'Last Update Posted (Estimated)' indicator was added.SummaryDifference1%

- Check62 days agoChange Detected- Added a government funding lapse notice and operating-status guidance, and confirmed the NIH Clinical Center is open with sources. - Version updated from v3.1.0 to v3.2.0.SummaryDifference6%

- Check69 days agoChange DetectedUpdated page version to v3.1.0 and added a contact phone number (502-629-3323); previous version was v3.0.2.SummaryDifference0.1%

- Check84 days agoChange DetectedUpdated the page revision from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.4%

Stay in the know with updates to Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy+IRE in Pancreatic Adenocarcinoma Clinical Trial page.